Phase I/II trial of nimotuzumab in combination with radiotherapy in patients with stage IIb-III non-small cell lung cancer.

Trial Profile

Phase I/II trial of nimotuzumab in combination with radiotherapy in patients with stage IIb-III non-small cell lung cancer.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 03 Jun 2008

At a glance

  • Drugs Nimotuzumab (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Jun 2008 Updated preliminary results presented at ASCO 2008.
    • 08 May 2008 Status change from recruiting to in progress, according to YM Biosciences.
    • 10 Apr 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top